礼来携手英伟达打造制药行业最强AI超级计算机

医药地理2025-11-01

近日，礼来公司宣布将携手英伟达（NVIDIA），共同打造一个由制药企业拥有并运营的、算力最强大的超级计算机。这台超级计算机将驱动一个“AI工厂”——一个专业化的计算基础设施，用于管理从数据输入、模型训练、参数微调到大规模推理的完整人工智能生命周期。这台超级计算机是全球首台采用DGX B300系统的英伟达DGX SuperPOD。它由超过1000块B300 GPU提供算力，并构建在统一的网络架构之上...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2580468614?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-01 09:54","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2580468614","market":"us","top_or_hot":-1,"title":"礼来携手英伟达打造制药行业最强AI超级计算机","media":"医药地理","content":"<div>\n<p>近日，礼来公司宣布将携手英伟达（NVIDIA），共同打造一个由制药企业拥有并运营的、算力最强大的超级计算机。这台超级计算机将驱动一个“AI工厂”——一个专业化的计算基础设施，用于管理从数据输入、模型训练、参数微调到大规模推理的完整人工智能生命周期。这台超级计算机是全球首台采用DGX B300系统的英伟达DGX SuperPOD。它由超过1000块B300 GPU提供算力，并构建在统一的网络架构之上...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251101095928a6d9be50&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>礼来携手英伟达打造制药行业最强AI超级计算机</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n礼来携手英伟达打造制药行业最强AI超级计算机\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-01 09:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251101095928a6d9be50&s=b><strong>医药地理</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，礼来公司宣布将携手英伟达（NVIDIA），共同打造一个由制药企业拥有并运营的、算力最强大的超级计算机。这台超级计算机将驱动一个“AI工厂”——一个专业化的计算基础设施，用于管理从数据输入、模型训练、参数微调到大规模推理的完整人工智能生命周期。这台超级计算机是全球首台采用DGX B300系统的英伟达DGX SuperPOD。它由超过1000块B300 GPU提供算力，并构建在统一的网络架构之上...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251101095928a6d9be50&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2381873111.SGD","symbol_name":"BGF SYSTEMATIC GLOBAL EQUITY HIGH INCOME \"A6\" (SGDHDG) INC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251101095928a6d9be50&s=b","article_id":"2580468614","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251101095928a6d9be50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2580468614","pubTimestamp":1761962097,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"近日，礼来公司宣布将携手英伟达，共同打造一个由制药企业拥有并运营的、算力最强大的超级计算机。这台全新的超级计算机和AI工厂实现了快速的自主学习和迭代。除了药物发现，礼来还计划借助该超级计算机缩短药物研发周期，加速新药上市惠及患者。在生产制造环节，数字孪生技术与英伟达的机器人技术相结合，有望优化生产效率，减少设备停机时间。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2381873111.SGD":"BGF SYSTEMATIC GLOBAL EQUITY HIGH INCOME \"A6\" (SGDHDG) INC","NVD2.UK":"2X NVIDIA ETP","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","LU1992135399.USD":"Allianz Global Intelligent Cities AT Acc USD","IE00B19Z8X17.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH  \"AG\" (USD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","NVD3.UK":"LS 3X NVIDIA","SNVD.UK":"LS -1X NVIDIA","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU1261432733.SGD":"Fidelity World A-ACC-SGD","NVDS.UK":"LS -1X NVIDIA","BK4549":"软银资本持仓","IE00BMPRXQ63.HKD":"NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY FUND \"A\" (HKDHDG) ACC","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","LU0109392836.USD":"富兰克林科技股A","LU2430703095.HKD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (HKD) INC","3NVD.UK":"LS 3X NVIDIA","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC","BK4548":"巴美列捷福持仓","BK4605":"半导体精选","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","IE00B5949003.HKD":"JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION \"A\" (HKD) ACC","LU2111349929.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (HKD) INC","NVDA":"英伟达","NVDS":"1.5倍做空NVDA ETF-Tradr","NVIW.SI":"NVDA 3xLongSG261006","NVDU":"2倍做多NVDA ETF-Direxion","LU0077335932.USD":"FIDELITY AMERICAN GROWTH \"A\" INC","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","LU1366333091.USD":"FIDELITY GLOBAL FOCUS \"A\" (USD) ACC","LLY":"礼来","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","LU0724617625.USD":"BGF GLOBAL ALLOCATION \"A4\" (USD) INC","2NVD.UK":"2X NVIDIA ETP","NVDX":"2倍做多NVDA ETF-T-Rex","LU1917777945.USD":"安联专题基金Cl AT Acc","LU0494093205.USD":"贝莱德ESG灵活多元资产A2 USD-H","LU1037948541.HKD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (HKD) ACC","NVD":"2倍做空NVDA ETF-GraniteShares","NVDY":"NVDA期权收益策略ETF-YieldMax","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","LU1934455194.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (USD) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU0265550946.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A5\" (USD) INC","LU2242650005.HKD":"FIDELITY FUNDS GLOBAL MULTI ASSET DYNAMIC \"A\" (HKD) ACC","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","NVDD":"1倍做空NVDA ETF-Direxion","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC"},"translate_title":"Eli Lilly joins hands with Nvidia to build the most powerful AI supercomputer in the pharmaceutical industry","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVD":0.6,"NVDU":0.6,"NVDA":1.5,"NVDX":0.6,"NVD2.UK":0.6,"NVDS.UK":0.6,"SNVD.UK":0.6,"NVDY":0.6,"NVIW.SI":0.6,"NVDD":0.6,"NVDS":0.6,"LLY":1.5,"NVD3.UK":0.6,"2NVD.UK":0.6,"3NVD.UK":0.6},"content_text":"近日，礼来公司宣布将携手英伟达（NVIDIA），共同打造一个由制药企业拥有并运营的、算力最强大的超级计算机。这台超级计算机将驱动一个“AI工厂”——一个专业化的计算基础设施，用于管理从数据输入、模型训练、参数微调到大规模推理的完整人工智能生命周期。这台超级计算机是全球首台采用DGX B300系统的英伟达DGX SuperPOD。它由超过1000块B300 GPU提供算力，并构建在统一的网络架构之上。这意味着跨GPU、存储和相关系统间的通信，全部都仅通过一个高速网络完成，极大地提升效率。这台全新的超级计算机和AI工厂实现了快速的自主学习和迭代。科学家将利用数百万次实验数据来训练AI模型，用以筛选潜在药物，从而极大拓展药物发现工作的探索范围和研发精度。其中一些专有AI模型将在礼来Lilly TuneLab平台上提供。Lilly TuneLab是一个协同共创的联邦式AI/ML药物发现平台，旨在扩大生物制药生态系统对先进发现工具的使用范围。TuneLab将继续优化发展其现有的模型组合，并计划引入整合了英伟达Clara精选开源模型的新工作流程。除了药物发现，礼来还计划借助该超级计算机缩短药物研发周期，加速新药上市惠及患者。新的科学AI智能体将协助研究人员在数字和实体环境中进行推理、规划和协同工作。借助先进的医学影像AI分析，科学家能够更清晰地了解疾病的进展过程，并开发新的生物标志物，为实现个体化诊疗提供支持。在生产制造环节，数字孪生技术与英伟达的机器人技术相结合，有望优化生产效率，减少设备停机时间。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2580468614","isCrawlerRequest":true}